Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Takai, Toshihide; Furukawa, Tomohiro; Watanabe, Shigeki*; Ishioka, Noriko*
Mechanical Engineering Journal (Internet), 9(4), p.21-00397_1 - 21-00397_11, 2022/08
For the mass production of astatine-211, a promising radiopharmaceutical for cancer treatment, the National Institute for Quantum and Radiological Science and Technology has proposed the innovative "Liquid Bismuth Target System." The target window in this system must be made from a material that resists the highly corrosive liquid bismuth environment. To meet this requirement, a promising target window material was selected in corrosion experiments performed in stagnant liquid bismuth. Based on knowledge of corrosion in liquid lead-bismuth eutectic gained during the development of fast reactors and accelerator-driven subcritical systems, experiments were carried out under saturated dissolved oxygen and low oxygen conditions, and the corrosion behaviors of the specimens were evaluated. The FeCrAl-alloy exhibited the most excellent corrosion resistance, followed by FeCrMo-alloy. Both materials are suitable candidates for the target window.
evaluation of F(
-
I)KCCYSL for targeting HER2Sasaki, Ichiro; Watanabe, Shigeki; Ohshima, Yasuhiro; Sugo, Yumi; Yamada, Keiichi*; Hanaoka, Hirofumi*; Ishioka, Noriko
Peptide Science 2015, p.243 - 246, 2016/03
Mori, Masanobu*; Sagara, Katsuya*; Arai, Kaori*; Nakatani, Nobutake*; Ohira, Shinichi*; Toda, Kei*; Itabashi, Hideyuki*; Kozaki, Daisuke*; Sugo, Yumi; Watanabe, Shigeki; et al.
Journal of Chromatography A, 1431, p.131 - 137, 2016/01
Times Cited Count：10 Percentile：41.68(Biochemical Research Methods)
radionuclide therapyOgawa, Kazuma*; Mizuno, Yoshiaki*; Washiyama, Koshin*; Shiba, Kazuhiro*; Takahashi, Naruto*; Kozaka, Takashi*; Watanabe, Shigeki; Shinohara, Atsushi*; Odani, Akira*
Nuclear Medicine and Biology, 42(11), p.875 - 879, 2015/11
Times Cited Count：23 Percentile：70.83(Radiology, Nuclear Medicine & Medical Imaging)Watanabe, Shigeki
Hoshasen To Sangyo, (138), p.52 - 54, 2015/06
no abstracts in English
Li + 
Pb reactionNishinaka, Ichiro; Yokoyama, Akihiko*; Washiyama, Koshin*; Maeda, Eita*; Watanabe, Shigeki; Hashimoto, Kazuyuki; Ishioka, Noriko; Makii, Hiroyuki; Toyoshima, Atsushi; Yamada, Norihiro*; et al.
Journal of Radioanalytical and Nuclear Chemistry, 304(3), p.1077 - 1083, 2015/06
Times Cited Count：9 Percentile：60.64(Chemistry, Analytical)Production cross sections of astatine isotopes 
At in the 29-57 MeV Li induced reaction with Pb target have been measured by - and 
-ray spectrometry. Excitation functions of production cross sections have been compared with a statistical model calculation to study the reaction mechanism of Li + Pb. Considerably small experimental cross sections of 
At and 
At compared with the calculation were clearly observed at incident energies higher than 44 MeV, indicating that the effects of breakup reaction play a role. A chemical separation of astatine from an irradiated lead target has been studied with a dry-distillation method. A complementary way to produce astatine isotopes has been developed.
Br--methyl-phenylalanine for tumor PET imagingHanaoka, Hirofumi*; Ohshima, Yasuhiro; Suzuki, Yurika*; Yamaguchi, Aiko*; Watanabe, Shigeki; Uehara, Tomoya*; Nagamori, Shushi*; Kanai, Yoshikatsu*; Ishioka, Noriko; Tsushima, Yoshito*; et al.
Journal of Nuclear Medicine, 56(5), p.791 - 797, 2015/05
Times Cited Count：18 Percentile：62.62(Radiology, Nuclear Medicine & Medical Imaging)
evaluation of 
Cu-labeled peptide for tumor imagingSugo, Yumi; Sasaki, Ichiro; Watanabe, Shigeki; Ohshima, Yasuhiro; Ishioka, Noriko
JAEA-Review 2014-050, JAEA Takasaki Annual Report 2013, P. 100, 2015/03
Sasaki, Ichiro; Hanaoka, Hirofumi*; Yamada, Keiichi*; Watanabe, Shigeki; Sugo, Yumi; Ohshima, Yasuhiro; Suzuki, Hiroyuki; Ishioka, Noriko
Peptide Science 2014, p.257 - 260, 2015/03
Lu for radioimmunotherapyWatanabe, Satoshi; Hashimoto, Kazuyuki; Watanabe, Shigeki; Iida, Yasuhiko*; Hanaoka, Hirofumi*; Endo, Keigo*; Ishioka, Noriko
Journal of Radioanalytical and Nuclear Chemistry, 303(1), p.935 - 940, 2015/01
Times Cited Count：11 Percentile：67.3(Chemistry, Analytical)Sasaki, Ichiro; Yamada, Keiichi*; Watanabe, Shigeki; Hanaoka, Hirofumi*; Sugo, Yumi; Oku, Hiroyuki*; Ishioka, Noriko
JAEA-Review 2013-059, JAEA Takasaki Annual Report 2012, P. 96, 2014/03
Evaluation of Cu-labeled peptide for tumor imagingSugo, Yumi; Sasaki, Ichiro; Watanabe, Shigeki; Ohshima, Yasuhiro; Ishioka, Noriko
Peptide Science 2013, p.355 - 358, 2014/03
At] astatineBalkin, E. R.*; Hamlin, D. K.*; Gagnon, K.*; Chyan, M.-K.*; Pal, S.*; Watanabe, Shigeki; Wilbur, D. S.*
Applied Sciences (Internet), 3(3), p.636 - 655, 2013/09
Times Cited Count：33 Percentile：85.42(Chemistry, Multidisciplinary)-ray simultaneous imaging by using a Si/CdTe Compton cameraSuzuki, Yoshiyuki*; Yamaguchi, Mitsutaka; Odaka, Hirokazu*; Shimada, Hirofumi*; Yoshida, Yukari*; Torikai, Kota*; Sato, Takahiro; Arakawa, Kazuo*; Kawachi, Naoki; Watanabe, Shigeki; et al.
Radiology, 267(3), p.941 - 947, 2013/06
Times Cited Count：23 Percentile：65.03(Radiology, Nuclear Medicine & Medical Imaging)Br-labeled amino acid derivative for PET imaging of tumorHanaoka, Hirofumi*; Watanabe, Shigeki; Tominaga, Hideyuki*; Ohshima, Yasuhiro; Watanabe, Satoshi; Yamada, Keiichi*; Iida, Yasuhiko*; Ishioka, Noriko; Endo, Keigo*
JAEA-Review 2012-046, JAEA Takasaki Annual Report 2011, P. 89, 2013/01
no abstracts in English
Br]bromo--methyl-L-tyrosine, a novel tyrosine analog for PET imaging of tumorsOhshima, Yasuhiro; Hanaoka, Hirofumi*; Watanabe, Shigeki; Sugo, Yumi; Watanabe, Satoshi; Tominaga, Hideyuki*; Oriuchi, Noboru*; Endo, Keigo*; Ishioka, Noriko
JAEA-Review 2011-043, JAEA Takasaki Annual Report 2010, P. 91, 2012/01
BrWatanabe, Satoshi; Watanabe, Shigeki; Iida, Yasuhiko*; Hanaoka, Hirofumi*; Endo, Keigo*; Ishioka, Noriko
JAEA-Review 2011-043, JAEA Takasaki Annual Report 2010, P. 92, 2012/01
no abstracts in English
Eto, Masao*; Kamishima, Yoshio*; Okamura, Shigeki*; Watanabe, Osamu*; Oyama, Kazuhiro*; Negishi, Kazuo; Kotake, Shoji*; Sakamoto, Yoshihiko; Kamide, Hideki
Proceedings of International Conference on Fast Reactors and Related Fuel Cycles (FR 2009) (CD-ROM), 10 Pages, 2012/00
In the JSFR design, the diameter of the Reactor Vessel (RV) shall be minimized and the reactor internal structures shall be simplified for reduction in construction cost. The reduction in the RV diameter is achieved by adopting an advanced refueling system and the hot RV with high temperature wall. The flow velocity in the reactor upper plenum increases because the diameter of the RV is decreased. As the result, the coolant flow field in reactor upper plenum is severe. The optimization of the coolant flow field in the reactor upper plenum was carried out for prevention the cover gas entrainment and the vortex cavitations at the hot leg intake. In addition, structural integrities for seismic loadings and thermal loadings were evaluated because the design seismic loading was highly increased and the vessel wall is directly exposed to the thermal transients of the upper plenum. This paper describes the characteristics and the results of the design study of the reactor system.
Br]bromo--methyl-L-tyrosine, a novel tyrosine analog for positron emission tomography imaging of tumorsOhshima, Yasuhiro; Hanaoka, Hirofumi*; Watanabe, Shigeki; Sugo, Yumi; Watanabe, Satoshi; Tominaga, Hideyuki*; Oriuchi, Noboru*; Endo, Keigo*; Ishioka, Noriko
Nuclear Medicine and Biology, 38(6), p.857 - 865, 2011/08
Times Cited Count：14 Percentile：47.34(Radiology, Nuclear Medicine & Medical Imaging)Cu -labeled trastuzumab PETPaudyal, P.*; Paudyal, B.*; Hanaoka, Hirofumi*; Oriuchi, Noboru*; Iida, Yasuhiko*; Yoshioka, Hiroki*; Tominaga, Hideyuki*; Watanabe, Satoshi; Watanabe, Shigeki; Ishioka, Noriko; et al.
JAEA-Review 2010-065, JAEA Takasaki Annual Report 2009, P. 108, 2011/01
